Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Body's own cells injected into knee tendon shows promise

NCT ID NCT04753853

Disease control Sponsor: Istituto Ortopedico Rizzoli Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested an injection of stromal vascular fraction, a mixture of cells from the patient's own fat tissue, for patellar tendinopathy (jumper's knee). Thirty participants received the injection under ultrasound guidance. The goal was to see if it could improve symptoms and function, measured by a questionnaire called VISA-P.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
stromal vascular fraction injection
What this could lead to
If it works, this could offer a new treatment option for patellar tendinopathy that uses the body's own cells to help heal the tendon.
What could go wrong
This was a small, early study with only 30 participants and no comparison group. The results may not apply to everyone, and the procedure may not work better than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jul 2021

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ultrasound or MRI signs of patellar tendon pathology Exclusion Criteria: * BMI \> 30 * Patients suffering from: rheumatic diseases, diabetes, infectious processes, epilepsy, severe osteoporosis * Patients undergoing intra-tendon infiltration of another substance within the previous 6 months; * Patients who had patellar tendon surgery within the previous 12 months; * Immunodepression * On going systemic inflammatory diseases (stabilized outcomes of such diseases are not considered absolute contraindications).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patellar tendinitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease of the tendon patellar tendinitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Patellar tendinitis Patellar tendinopathy Tendinopathy

Contacts and locations

Locations

  • Istituto Ortopedico Rizzoli

    Bologna, 40124, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.